Table 1. Characteristics of published studies included in this meta-analysis.
First author & year | Ethnicity | Studydesign | CKDtype | Kidneyfunctionof case | Definition of case |
Shaikh, 2012 [27] | Caucasian | CC | DN | non-ESRD | UAE >300 mg/day11 |
Rahimi, 2012 [28] | Caucasian | CS | DN | non-ESRD | ACR >30 mg/g |
El-Baz, 2012 [29] | Caucasian | CS | DN | non-ESRD | ACR >30 mg/g |
Zsom(1), 2011 [30] | Caucasian | CC | non-DN | non-ESRD | biopsy, ultrasound diagnosed & eGFR <60 ml/min/1.73 m2 |
Zsom(2), 2011 [30] | Caucasian | CC | DN | non-ESRD | proteinuria & eGFR <60 ml/min/1.73 m2 |
Al-Harbi, 2011 [31] | Caucasian | CC | DN | non-ESRD | no description |
Jung, 2011 [32] | Asian | CC | GN | non-ESRD | biopsy diagnosed |
Ali, 2011 [33] | Asian | CC | Comb | ESRD | doctor diagnosed |
Huang, 2010 [34] | Asian | CC | GN | ESRD | biopsy diagnosed |
Jayapalan, 2010 [35] | Asian | CS | DN | non-ESRD | ACR >30 mg/g or RRT |
Mansoor, 2010 [14] | Caucasian | CS | DN | non-ESRD | albuminuria or RRT |
Naresh, 2009 [36] | Asian | CC | DN | non-ESRD | no description |
Ezzidi, 2009 [37] | Caucasian | CS | DN | non-ESRD | ACR >30 mg/g or eGFR <90 ml/min/1.73 m2 |
Nikzamir, 2009 [38] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Anbazhagan, 2009 [39] | Asian | CC | Comb | ESRD | RRT |
Ahluwalia, 2009 [40] | Asian | CC | DN | non-ESRD | UAE >200 µg/min, ACR >300 mg/g orRRT |
Palomo-Piñón, 2009 [16] | Caucasian | CS | DN | non-ESRD | ACR >30 mg/g |
Möllsten, 2008 [41] | Caucasian | CS | DN | non-ESRD | ACR >20 mg/g |
Eroglu, 2008 [42] | Caucasian | CC | DN | non-ESRD | 30 mg/day<UAE <300 mg/day |
Arfa, 2008 [43] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Tripathi, 2008 [44] | Asian | CC | non-DN | ESRD | CCr <15 mL/min/1.73 m2 & ultrasound diagnosedor CT |
Movva, 2007 [45] | Asian | CC | DN | ESRD | SCr >1.5 mg/dL and UAE >30 mg/day |
Uddin, 2007 [46] | Asian | CC | DN | ESRD | porteinuria |
Buraczynska, 2006 [47] | Caucasian | CC | Comb | ESRD | RRT |
So, 2006 [48] | Asian | CS | DN | non-ESRD | ACR >30 mg/g |
Shestakova, 2006 [49] | Caucasian | CC | DN | non-ESRD | ACR >300 mg/g |
Ng, 2006 [50] | Caucasian | CS | DN | non-ESRD | urinalyses positive, ACR >250 mg/g (men) or >355 mg/g (women) |
Prasad, 2006 [51] | Asian | CC | DN | non-ESRD | SCr >3 mg/dL?ACR >200 mg/g |
Degirmenci, 2005 [52] | Caucasian | CS | DN | ESRD | UAE >30 mg/day |
van der Sman-de Beer, 2005 [53] | Caucasian | CC | Comb | non-ESRD | RRT |
Park, 2005 [18] | Asian | CC | DN | ESRD | RRT |
Canani, 2005 [54] | Caucasian | CS | DN | non-ESRD | UAE >20 µg/min |
Fabris, 2005 [55] | Caucasian | CC | HN | non-ESRD | SCr >1.5 mg/dL |
Lau, 2004 [56] | Asian | CC | GN | ESRD | biopsy diagnosed |
Suzuki, 2004 [57] | Asian | CC | GN | non-ESRD | biopsy diagnosed |
Stratta, 2004 [58] | Caucasian | CC | GN | non-ESRD | biopsy diagnosed |
Lochynska, 2003 [59] | Caucasian | CC | GN | non-ESRD | biopsy diagnosed |
Papp, 2003 [60] | Caucasian | CC | GN | ESRD | RRT |
Aucella, 2003 [61] | Caucasian | CC | Comb | non-ESRD | RRT |
Okuno, 2003 [62] | Asian | CS | DN | non-ESRD | UAE >10 µg/min |
Ortiz, 2003 [63] | Caucasian | CC | non-DN | non-ESRD | CCr <50 mL/min/1.73 m2 |
Hadjadj, 2003 [15] | Caucasian | CC | DN | non-ESRD | urinary albumin concentration >20 mg/L |
Wang, 2003 [64] | Asian | CC | Comb | ESRD | RRT |
Dixit, 2002 [65] | Caucasian | CC | GN | ESRD | biopsy diagnosed |
Lee(1), 2002 [26] | Asian | CS | non-DN | non-ESRD | UAE >20 µg/min or ACR >20 mg/g |
Lee(2), 2002 [26] | Asian | CS | DN | non-ESRD | UAE >20 µg/min or ACR >20 mg/g |
Losito, 2002 [66] | Caucasian | CC | Comb | ESRD | RRT |
Yoon, 2002 [67] | Asian | CC | GN | non-ESRD | biopsy diagnosed |
Fradin, 2002 [68] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Drouet, 2002 [69] | Caucasian | CC | GN | non-ESRD | biopsy diagnosed |
Nicod, 2002 [70] | Caucasian | CC | Comb | non-ESRD | RRT |
Araz, 2001 [71] | Caucasian | CS | DN | non-ESRD | ACR >30 mg/g |
Azar, 2001 [72] | Caucasian | CC | DN | non-ESRD | UAE >30 mg/day |
Lovati, 2001 [73] | Caucasian | CC | Comb | ESRD | RRT |
Wang, 2001 [74] | Caucasian | CS | Comb | non-ESRD | CCr <60 mL/min/1.73 m2 |
Taniwaki, 2001 [75] | Asian | CS | DN | non-ESRD | UAE >30 mg/day |
Viswanathan, 2001 [76] | Asian | CC | DN | non-ESRD | proteinuria >500 mg/dL |
Hadjadj, 2001 [77] | Caucasian | CS | DN | non-ESRD | urinary albumin concentration >20 mg/L |
Wu, 2000 [78] | Asian | CC | DN | non-ESRD | no description |
Hsieh, 2000 [79] | Asian | CC | DN | non-ESRD | proteinuria >500 mg/dL |
van Ittersum, 2000 [80] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Tomino, 1999 [19] | Asian | CS | DN | non-ESRD | UAE >20 µg/min or ACR >30 mg/g |
Solini, 1999 [81] | Caucasian | CS | DN | non-ESRD | Albuminuria |
De Cosmo, 1999 [82] | Caucasian | CC | DN | non-ESRD | UAE >30 mg/day |
Miura, 1999 [83] | Asian | CS | DN | non-ESRD | UAE >10 µg/min |
Kuramoto, 1999 [84] | Asian | CS | DN | non-ESRD | UAE >15 µg/min |
Huang, 1998 [85] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Walder, 1998 [86] | Caucasian | CC | DN | non-ESRD | UAE >30 mg/day |
Freire, 1998 [87] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Grzeszczak, 1998 [88] | Caucasian | CS | DN | non-ESRD | ACR >1.9 mg/mol (men) or >2.8 mg/mol (women) |
Young, 1998 [89] | Asian | CS | DN | non-ESRD | UAE >30 mg/day |
Penno, 1998 [90] | Caucasian | CS | DN | non-ESRD | UAE >20 µg/min |
Fernández-Llama, 1998 [91] | Caucasian | CS | HN | non-ESRD | UAE >20 µg/min |
Frost, 1998 [92] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Pei, 1997 [93] | Caucasian | CS | GN | non-ESRD | biopsy diagnosed |
Marre, 1997 [94] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Barnas, 1997 [95] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Ringel, 1997 [96] | Caucasian | CC | DN | non-ESRD | UAE >30 mg/day |
Schmidt, 1997 [97] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Kawada, 1997 [98] | Asian | CC | Comb | ESRD | RRT |
Kario, 1997 [99] | Asian | CS | HN | non-ESRD | UAE >15 µg/min |
Nakajima, 1996 [17] | Asian | CS | DN | non-ESRD | ACR >30 mg/g |
Chowdhury, 1996 [100] | Caucasian | CS | DN | non-ESRD | Albuminuria |
McLaughlin, 1996 [101] | Caucasian | CC | Comb | non-ESRD | RRT or doctor diagnosed |
Oh, 1996 [102] | Asian | CS | DN | non-ESRD | UAE >20 µg/min |
Schmidt, 1996 [103] | Caucasian | CC | Comb | ESRD | RRT |
Doi, 1996 [104] | Asian | CS | DN | non-ESRD | ACR >30 mg/g |
Ohno, 1996 [105] | Asian | CS | DN | non-ESRD | ACR >10 mg/g |
Mizuiri, 1995 [106] | Asian | CC | DN | non-ESRD | UAE >20 µg/min or RRT |
Yorioka, 1995 [107] | Asian | CC | GN | non-ESRD | biopsy diagnosed |
Fujisawa, 1995 [108] | Asian | CS | DN | non-ESRD | Albuminuria or RRT |
Panagiotopoulos, 1995 [109] | Caucasian | CS | DN | non-ESRD | UAE >20 µg/min |
Tarnow, 1995 [110] | Caucasian | CC | DN | non-ESRD | UAE >300 mg/day or biopsy diagnosed |
Schmidt, 1995 [111] | Caucasian | CC | GN | non-ESRD | biopsy diagnosed |
Yoshida, 1995 [112] | Asian | CC | GN | non-ESRD | biopsy diagnosed |
Dudley, 1995 [113] | Caucasian | CC | DN | non-ESRD | patients with urine in top tertile of the median UAE |
Harden, 1995 [114] | Caucasian | CC | GN | non-ESRD | biopsy diagnosed |
Doria, 1994 [115] | Caucasian | CC | DN | non-ESRD | UAE >30 µg/min |
Marre, 1994 [116] | Caucasian | CS | DN | non-ESRD | UAE >30 mg/day |
Powrie, 1994 [117] | Caucasian | CS | DN | non-ESRD | ACR >3 mg/mmol |
CC: case control study; CS: cross-sectional survey; DN: diabetic nephropathy; non-DN: non diabetic nephropathy; GN: glomerulonephritis; HN: hypertensive nephropathy; Comb: combined; ESRD: only ESRD patients; non-ESRD: not only ESRD patients; UAE: urinary albumin excretion rate; ACR: Albumin creatinine ratio; eGFR: estimated glomerular filtration rate; CCr: creatinine clearance; RRT: renal replacement therapy; CT: computed tomography; SCr: serum creatinine.